HopeStage
Back to all studies
CompletedNCT01331330

Two Brain-Stimulation Settings for Treatment-Resistant Depression

About this titleRead the official source — NCT01331330
Device studyAges 21–70Multiple countries
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 70 years.

Listed locations
Nice and 4 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2011
Recruitment status
Completed
Enrollment listed in the registry
9
Sponsor
Abbott Medical Devices
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
France, United Kingdom, Israel
Age range
From 21 Years to 70 Years
Official registry ID
NCT01331330
Official title
Show the full official title

A Clinical Evaluation of Different Device Parameters for the Management of Patients With Treatment Resistant Major Depressive Disorder, Single or Recurrent Episode, With Deep Brain Stimulation

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Nice, France · Paris, France · Jerusalem, Israel

1 more locations
  • London, United Kingdom
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Abbott Medical Devices.

Who was this study for?

Listed age limits: 21 years to 70 years.

Want to explore more studies?

Explore studies